Skip to main content
Category

Research Area

CancerCancerCancer and Cell BiologyDisease AreaImmunotherapyLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsResearchTumoursxOncofetal Ecosystem

New biomarker predicts liver cancer recurrence and immunotherapy response

By | Cancer, Cancer, Cancer and Cell Biology, Disease Area, Immunotherapy, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research, Tumours, xOncofetal Ecosystem

Analysis of the environment that surrounds liver cancer tumours has revealed that patients with a high concentration of a certain cell type have early return of aggressive cancer but do…

Cardiovascular DiseaseCardiovascular DiseaseCardiovascular Science and Diabetes ProgramDiabetesFundingNews & EventsResearch

Federal government supports new treatment to clear blocked arteries

By | Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Diabetes, Funding, News & Events, Research

A Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The…

Breast CancerBreast CancerCancerCancerCancer EpigeneticsCardiovascular DiseaseCardiovascular DiseaseEpigenetics and Genomics LaboratoryFundingGenome Biology and Genetic DiseasesMedia ReleasesMitochondrial DiseaseMitochondrial diseaseMitochondrial Medicine and BiologyNews & EventsResearchTranslation

WA researchers excel in nationally competitive grants

By | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cardiovascular Disease, Cardiovascular Disease, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Media Releases, Mitochondrial Disease, Mitochondrial disease, Mitochondrial Medicine and Biology, News & Events, Research, Translation

Eight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have…

CancerCancerFundingMelanomaMelanoma DiscoveryMelonomaNews & EventsPersonalised MedicineResearch

$3.5 million research collaborative brings cell therapy for solid cancers to WA

By | Cancer, Cancer, Funding, Melanoma, Melanoma Discovery, Melonoma, News & Events, Personalised Medicine, Research

Researchers from the Western Australia Melanoma Initiative (WAMI), a cancer research collaborative, will implement a specialised immune cell therapy for cancer patients in WA, thanks to a $2.5 million grant…

Development of Improved Diagnostics for Genetic DiseaseDevelopment of Therapies for Selected Genetic Muscle DiseasesDisease AreaFundingGenesGenetic DiseaseGenetic DiseaseGenetic Neuromuscular DisordersGeneticsMedia ReleasesMusclesMuscular DystrophyNeurological DisordersNews & EventsRare Disease Genetics and Functional Genomics

WA scientists win Hearts and Minds

By | Development of Improved Diagnostics for Genetic Disease, Development of Therapies for Selected Genetic Muscle Diseases, Disease Area, Funding, Genes, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Media Releases, Muscles, Muscular Dystrophy, Neurological Disorders, News & Events, Rare Disease Genetics and Functional Genomics

First West Australian team to attract unique listed investment company funds One of Australia's Top 30 Corporate Philanthropists, Hearts and Minds Investments Limited (ASX: HM1) has made its first donation…

CancerCancerCancer EpigeneticsDisease AreaEpigenetics and Genomics LaboratoryLabLiverLiver CancerLiver CancerLiver DiseaseMitochondrial Medicine and BiologyNews & EventsResearch

New discovery for treatment of primary liver cancer shows promise

By | Cancer, Cancer, Cancer Epigenetics, Disease Area, Epigenetics and Genomics Laboratory, Lab, Liver, Liver Cancer, Liver Cancer, Liver Disease, Mitochondrial Medicine and Biology, News & Events, Research

A study using preclinical models has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer…